1. MIR4435-2HG: A newly proposed lncRNA in human cancer
    Menggang Zhang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  2. The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions
    Martina Duca et al, 2022, International Journal of Molecular Sciences CrossRef
  3. MIR4435-2HG: A Tumor-associated Long Non-coding RNA
    Fangnan Zhao et al, 2022, Current Pharmaceutical Design CrossRef
  4. Focal adhesion kinase: from biological functions to therapeutic strategies
    Ximin Tan et al, 2023, Experimental Hematology & Oncology CrossRef
  5. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
    Shangqi Cao et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
  6. Biology of GD2 ganglioside: implications for cancer immunotherapy
    Pierre Machy et al, 2023, Frontiers in Pharmacology CrossRef
  7. Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways
    Cécile Cumin et al, 2022, Cell Reports CrossRef
  8. A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma
    Ruijie Dang et al, 2022, International Journal of General Medicine CrossRef
  9. Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
    Majid Ghasemian et al, 2022, Cancer Cell International CrossRef
  10. Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression
    Fang Zuo et al, 2021, Bioengineered CrossRef
  11. Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
    Mohammad Taheri et al, 2023, Frontiers in Oncology CrossRef
  12. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
    Chenming Zhong et al, 2022, Frontiers in Immunology CrossRef
  13. Targeting PI3K/Akt signaling in prostate cancer therapy
    Mehrdad Hashemi et al, 2023, Journal of Cell Communication and Signaling CrossRef
  14. Roles and inhibitors of FAK in cancer: current advances and future directions
    Hui-Hui Hu et al, 2024, Frontiers in Pharmacology CrossRef
  15. Sialylated glycoproteins as biomarkers and drivers of progression in prostate cancer
    Ru Wen et al, 2022, Carbohydrate Research CrossRef
  16. RAB11A Promotes Cell Malignant Progression and Tumor Formation of Prostate Cancer via Activating FAK/AKT Signaling Pathway
    Weifang Chen et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
  17. The Role of Anesthetic Drugs and Statins in Prostate Cancer Recurrence: Starting at the Actual Knowledge and Walking through a New Paradigm
    Aida Raigon Ponferrada et al, 2023, Cancers CrossRef
  18. Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
    Zhou Chen et al, 2023, Current Issues in Molecular Biology CrossRef
  19. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior
    Aaqib M. Bhat et al, 2024, Scientific Reports CrossRef
  20. Long non-coding RNA CRNDE exacerbates NPC advancement mediated by the miR-545-5p/CCND2 axis
    Sichen Ge et al, 2021, Cancer Cell International CrossRef
  21. Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer
    Zhiquan Hu et al, 2022, Genes CrossRef
  22. Decreased levels of PTCSC3 promote the deterioration of prostate cancer and affect the prognostic outcome of patients through sponge miR-182-5p
    Lin Cheng et al, 2024, BMC Urology CrossRef
  23. Role of GD3 Synthase ST8Sia I in Cancers
    Angelina Kasprowicz et al, 2022, Cancers CrossRef
  24. Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils
    Hongfei Yu et al, 2022, Cancer Immunology Research CrossRef
  25. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
    Sepideh Mirzaei et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef